Bryan Therapeutics Warns Consumers About Counterfeit Nitric Oxide Products

Bryan Therapeutics has issued a warning about counterfeit versions of its N1o1 and NO2U nitric oxide products, expressing serious concerns about consumer safety and product integrity. According to the company, products appearing to originate from Bryan Therapeutics but sold by unauthorized sellers may be stolen goods or counterfeit, presenting significant health risks to consumers. The company emphasizes that these unauthorized products are not authentic and cannot guarantee their efficacy or safety since the contents are unknown.

Dr. Nathan S. Bryan, CEO of Bryan Therapeutics Inc., stated that the company produces nitric oxide-based consumer products based on over 25 years of research, discoveries, and innovation. He explained that their products are market leaders because they actually produce nitric oxide when consumed or administered, unlike other products marketed as nitric oxide. Recently, the company has identified numerous counterfeit products using its trademarked brands, which represent a severe safety concern. Dr. Bryan emphasized that safety and product integrity are top priorities for the company, and they take this issue seriously.

Susan Shaffer, President of Bryan Therapeutics Inc., provided specific guidance for consumers shopping online. She advised buying only from www.N1o1.com, www.NO2U.com, or authorized Amazon listings. On Amazon, products must show "Sold By: Pneuma Nitric Oxide LLC, NO2U, or Bryan Nitriceuticals" to ensure authenticity. Shaffer noted that the safest option is to buy directly from the company's website or Amazon store, as Bryan Therapeutics does not sell on eBay or other third-party sites besides Amazon and their N1o1 storefront.

The company has retained legal counsel to address the counterfeit issue. Wesley E. Johnson of Cross-Border Counselor LLP at www.cbcounselor.com will assist Bryan Therapeutics with proactive measures to protect its clients, including initiating legal action against counterfeiters and other illicit sellers. This legal action underscores the seriousness with which the company views the proliferation of counterfeit products and their potential harm to consumers.

The warning highlights broader implications for consumer safety in the online marketplace, particularly for health and wellness products. Counterfeit products not only undermine brand integrity but also pose direct health risks to consumers who may unknowingly purchase ineffective or potentially harmful substances. The situation also raises questions about platform accountability, as unauthorized sellers operate on major e-commerce sites despite company efforts to maintain control over distribution channels.

For consumers, this announcement serves as a critical reminder to verify the authenticity of health products purchased online, especially those claiming specific therapeutic benefits. The company's direct guidance about authorized sellers provides clear parameters for safe purchasing, while the legal actions signal a commitment to protecting both the brand and consumers from fraudulent activities in the marketplace.